MeiraGTx Holdings Plc (MGTX)
10.69
+0.19
(+1.81%)
USD |
NASDAQ |
Oct 09, 16:00
10.90
+0.21
(+1.96%)
After-Hours: 20:00
MeiraGTx Holdings Net Income (Quarterly) : 160.67M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 160.67M |
| March 31, 2026 | -46.31M |
| December 31, 2025 | 15.09M |
| September 30, 2025 | -50.51M |
| June 30, 2025 | -38.80M |
| March 31, 2025 | -39.98M |
| December 31, 2024 | -39.40M |
| September 30, 2024 | -39.33M |
| June 30, 2024 | -48.62M |
| March 31, 2024 | -20.44M |
| December 31, 2023 | 20.22M |
| September 30, 2023 | -44.30M |
| June 30, 2023 | -29.58M |
| March 31, 2023 | -30.36M |
| September 30, 2022 | -37.28M |
| June 30, 2022 | -33.97M |
| March 31, 2022 | -31.04M |
| December 31, 2021 | -9.912M |
| Date | Value |
|---|---|
| September 30, 2021 | -25.94M |
| June 30, 2021 | -20.09M |
| March 31, 2021 | -23.62M |
| December 31, 2020 | -10.46M |
| September 30, 2020 | -6.432M |
| June 30, 2020 | -25.42M |
| March 31, 2020 | -15.68M |
| December 31, 2019 | -5.481M |
| September 30, 2019 | -10.46M |
| June 30, 2019 | -20.82M |
| March 31, 2019 | -17.98M |
| December 31, 2018 | -21.06M |
| September 30, 2018 | -15.42M |
| June 30, 2018 | -30.46M |
| March 31, 2018 | -16.40M |
| September 30, 2017 | -8.503M |
| June 30, 2017 | -7.179M |
| March 31, 2017 | -6.820M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Xencor, Inc. | -21.73M |
| UroGen Pharma Ltd. | -14.35M |
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Viking Therapeutics, Inc. | -128.02M |
| IDEAYA Biosciences, Inc. | -112.45M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 321.43M |
| Total Expenses (Quarterly) | 160.71M |
| EPS Diluted (Quarterly) | 1.713 |
| Enterprise Value | 958.34M |
| Gross Profit Margin (Quarterly) | 96.89% |
| Profit Margin (Quarterly) | 49.99% |
| Earnings Yield | 6.60% |
| Operating Earnings Yield | 20.27% |
| Normalized Earnings Yield | 6.488 |